About this trial
Stroke survivors with lower limb disability can improve their walking speed with high-intensity interval training (HIIT) rehabilitation therapy. However, some individuals may not respond to HIIT even when fully adherent to the program. To address this, the investigators propose to build a predictive model that identifies if a Veteran with chronic subcortical stroke will improve their walking speed with HIIT by incorporating blood lactate as an early predictor of exercise response, and inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and regional cerebral blood flow (CBF) as predictors of the brain's potential to respond, while also taking into consideration other factors such as comorbidities, demographics, and fitness levels.
Eligibility criteria
Qualifiers
chronic left or right subcortical stroke as defined by 6 months or more after a cardiovascular accident
lower extremity motor impairment due to stroke that causes a walking speed of less than 0.6 m/s during a 10m walk
Veteran status
Disqualifiers
MRI contraindications, including implanted cardiac pacemakers and severe claustrophobia
any neurodegenerative condition other than stroke that may lead to lower extremity impairment
a visual or auditory impairment that may hinder study procedures
any medical condition that would preclude participation in a physical exercise intervention program
Trial design
Treatments tested in this trial
- High Intensity Interval Training (HIIT)
Treatment groups
Sponsors and collaborators
VA Office of Research and Development
Lead sponsor
Atlanta VA Medical Center
Collaborator